Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

MRSA AI Diagnostics Software Helps Enhance Microbiology Lab Efficiency and Workflow

By LabMedica International staff writers
Posted on 29 May 2023

Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant risk in hospital environments, leading to serious complications like bloodstream or surgical-site infections, sepsis, and even death. More...

Lab tests are necessary to confirm whether an infection is due to MRSA, and the capacity to conduct these tests efficiently and effectively could profoundly influence patient care. However, labs often face hurdles such as fluctuating sample volumes, staff shortages, financial constraints from budget cuts, and shifting diagnostic methods. To address these challenges and facilitate efficient, timely, and cost-effective clinical bacteriological testing, a new solution now offers comprehensive lab automation for clinical microbiology laboratories.

Becton, Dickinson and Company’s (BD, Franklin Lakes, NJ, USA) new BD Kiestra MRSA imaging application employs artificial intelligence (AI) to analyze bacterial growth and release negative samples with minimal human intervention. The BD Kiestra MRSA application employs AI to automate the traditionally laborious and time-consuming task of inspecting Petri dishes to ascertain bacterial growth, allowing medical lab scientists and technicians to devote more time to high-priority analyses.

The application can evaluate individual samples or group together numerous plates showing non-significant growth for batch review and release of negative results, potentially easing the administrative load on technicians. The MRSA imaging application utilizes AI algorithms to identify specific culture characteristics on the BBL CHROMagar MRSA II plate. Based on this information and analysis by BD Synapsys informatics, plate images are automatically arranged and sorted into meaningful worklists for lab scientists and technicians. This AI-driven imaging application, backed by the BD BBL CHROMagar MRSA II screening plates and powered by BD Synapsys Informatics Solution, is compatible with both standalone BD Kiestra ReadA systems and track-based BD Kiestra lab automation solutions.

"The pandemic created significant and ongoing labor challenges in laboratories, and reading plates is a labor-intense, potentially error-prone process in microbiology," said Nikos Pavlidis, vice president and general manager for Diagnostics at BD. "The use of this imaging application to automatically organize specimens in meaningful worklists helps use limited laboratory staff more efficiently and allows lab personnel to bring their expertise to bear on more critical and complex specimens."

Related Links:
BD 


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.